Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-20Clinical Trial Update: Efficacy of Dietary Sodium Restriction of Improving Vascular Endothelial Function in Middle Aged and Older Adults [NA]
This entry reports on a completed clinical trial evaluating whether dietary sodium restriction improves vascular endothelial function in mid…
-
CLINICAL_TRIALS trial_result · 2014-06-17Clinical Trial Update: Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study) [Phase 4]
A Phase 4 clinical trial update evaluating the metabolic effects of antihypertensive medications in people with metabolic syndrome; the stud…
-
CLINICAL_TRIALS trial_result · 2014-06-17Clinical Trial Update: 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 12-week study evaluating the efficacy and safety of empagliflozin in patients with type 2 diabetes mellitus and hypertension; the tr…
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: Personalized Physician Learning to Improve Hypertension Care [NA]
A clinical trial evaluating a personalized physician education program to improve hypertension care has completed.
-
CLINICAL_TRIALS research · 2014-06-16Clinical Trial Update: Effects of Renal Sympathetic Denervation on the Cardiac and Renal Functions in Patients With Drug-resistant Hypertension Through MRI Evaluation [NA]
This clinical trial evaluates the effects of renal sympathetic denervation on cardiac and renal function in patients with uncontrolled hyper…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-06-13FDA Approved: LISINOPRIL — Supplemental Application (Aurobindo Pharma Limited)
The FDA granted a supplemental approval for lisinopril under ANDA077622 for Aurobindo Pharma Limited.
-
FDA approval · 2014-06-13FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) submitted by Cosette Pharmaceuticals, In…
-
FDA approval · 2014-06-13FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Benicar HCT, combining olmesartan medoxomil with hydrochlorothiazide, for hypertension; appr…
-
FDA approval · 2014-06-13FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA granted a supplemental approval for Tribenzor (olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide) submitted by Cosette Ph…
-
FDA approval · 2014-06-13FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Benicar (olmesartan medoxomil) from Cosette Pharmaceuticals, Inc.
-
FDA approval · 2014-06-12FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for the fixed-dose combination of bisoprolol fumarate and hydrochlorothiazide. This combination …
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: Effectiveness of a Barbershop-Based Program to Improve High Blood Pressure Control and Awareness in Black Men [NA]
A completed trial evaluating whether a barber shop–based program can improve high blood pressure control and awareness among Black men.
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: The Efficacy of Wet Cupping on Blood Pressure Among Hypertension Patients [NA]
A completed clinical trial evaluated the effect of wet cupping on blood pressure in adults with hypertension, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: Efficacy of Wet Cupping on Blood Pressure Among Hypertension Patients [NA]
A completed clinical study from King Abdulaziz University assessed whether wet cupping lowers blood pressure in people with hypertension, wi…
-
FDA approval · 2014-06-11FDA Approved: DOXAZOSIN — Original Application (Accord Healthcare Inc.)
FDA approval of Accord Healthcare Inc.'s original application for generic doxazosin (DOXAZOSIN), an alpha-1 blocker indicated for hypertensi…
-
FDA approval · 2014-06-09FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Exforge (amlodipine besylate and valsartan) from Novartis Pharmaceuticals Corporation.
-
FDA approval · 2014-06-09FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXFORGE HCT (amlodipine valsartan and hydrochlorothiazide) from Novartis Pharmaceuticals Corpora…
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Effectiveness of Physical Activity Prescription Among Hypertensive Patients of Primary Health Care. [NA]
A completed clinical trial evaluated the effectiveness of prescribing physical activity for hypertensive patients in primary health care. Th…
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension [Phase 4]
A Phase 4 clinical trial update assessing the short-term efficacy of a Gastrodia and Uncaria drink for hypertension, focusing on masked hype…
-
FDA approval · 2014-06-05FDA Approved: PROCARDIA XL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Procardia XL (nifedipine) submitted by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Clevidipine Bolus Administration in the Treatment of Hypertensive Patients Undergoing Cardiac Surgery (SPRINT) [Phase 2]
Phase 2 trial update evaluating clevidipine bolus for hypertension in patients undergoing cardiac surgery; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Evaluating a Web-Based Cardiovascular Disease Risk Factor Reduction Program Among American Indians [NA]
A completed clinical trial evaluating a web-based program to reduce cardiovascular risk factors in American Indian populations.
-
CLINICAL_TRIALS research · 2014-06-04Clinical Trial Update: Effect of High Blood Pressure and Antihypertensive Treatment on Brain Functioning in Children [Phase 1]
A Phase 1 clinical trial investigating the effects of pediatric hypertension and its antihypertensive treatment on brain function has comple…
-
FDA approval · 2014-05-30FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approves a supplemental application for Diovan HCT (valsartan/hydrochlorothiazide) submitted by Novartis Pharmaceuticals Corporation. Th…
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: Sodium-Potassium Blood Pressure Trial in Children [Phase 4]
Phase 4 clinical trial in children evaluating the effect of sodium and potassium on blood pressure has completed.